Tonix Pharmaceuticals is currently recruiting participants in a Phase 3 trial for military-related posttraumatic stress disorder.  For more information, please visit or (NCT03062540).

Stock Info : Analyst Coverage

Analyst Coverage

Firm Analyst
Cantor Fitzgerald Chiara Russo
Edison Investment Research Maxim Jacobs, CFA
Oppenheimer Jay Olson
Roth Capital Partners Scott R. Henry, CFA


Tonix Pharmaceuticals Holding Corp. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Tonix Pharmaceuticals Holding Corp.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Tonix Pharmaceuticals Holding Corp. or its management. Tonix Pharmaceuticals Holding Corp. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.